Want to see IBRX full AI Analyst Report?
ImmunityBio (IBRX) Q2 2026 Earnings Report
IBRX Q2 2026 EPS Results
- Actual EPS
- -$0.22
- Consensus EPS
- -$0.08
- Beat/Miss
- Missed by -$0.14
- One Year Ago EPS
- -$0.10
IBRX Q2 2026 Revenue Results
- Actual Revenue
- $51.24M
- Expected Revenue
- $49.70M
- Beat/Miss
- Beat by +$1.54M
- YoY Revenue Growth
- +93.91%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- Before Open
- Conference Call
- Tuesday, August 4, 2026
IBRX Upcoming Earnings
ImmunityBio's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
IBRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.07- | -0.07 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -0.08-0.22 | -0.1 | -120.00% (-0.12) | |
| May 07, 2026 | 2026 (Q1) | -0.07-0.62 | -0.15 | -313.33% (-0.47) | |
| Mar 03, 2026 | 2025 (Q4) | -0.08-0.06 | -0.09 | 33.33% (+0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.11-0.07 | -0.14 | 50.00% (+0.07) | |
| Aug 05, 2025 | 2025 (Q2) | -0.11-0.10 | -0.2 | 50.00% (+0.10) | |
| May 12, 2025 | 2025 (Q1) | -0.13-0.15 | -0.2 | 25.00% (+0.05) | |
| Mar 03, 2025 | 2024 (Q4) | -0.20-0.09 | -0.36 | 75.00% (+0.27) | |
| Nov 12, 2024 | 2024 (Q3) | -0.18-0.14 | -0.19 | 26.32% (+0.05) | |
| Aug 09, 2023 | 2023 (Q2) | -0.23-0.32 | -0.24 | -31.25% (-0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed